1225278-74-9

Basic information

• Product Name: 4-(3-bromopyridin-4-yloxy)-2,5-difluorobenzenamine
• Synonyms: 4-(3-bromopyridin-4-yloxy)-2,5-difluorobenzenamine
• CAS NO: 1225278-74-9
• Molecular Weight: 301.09
• Mol File: 1225278-74-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 4-(3-bromopyridin-4-yloxy)-2,5-difluorobenzenamine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(3-bromopyridin-4-yloxy)-2,5-difluorobenzenamine(1225278-74-9)
• EPA Substance Registry System: 4-(3-bromopyridin-4-yloxy)-2,5-difluorobenzenamine(1225278-74-9)

Safety Data

• Hazardous Substances Data: 1225278-74-9(Hazardous Substances Data)

Upstream product

• 36953-42-1 3-bromo-4-chloropyridine 
• 120103-18-6 2.5-difluoro-4-nitrophenol 
• 1225278-73-8 3-bromo-4-(2,5-difluoro-4-nitrophenoxy)pyridine 

Downstream Products

• 1345855-17-5 N-(4-(3-bromopyridin-4-yloxy)-2,5-difluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide 
• 1345855-18-6 N-(4-(3-(1H-pyrazol-4-yl)pyridin-4-yloxy)-2,5-difluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide 
• 1345855-14-2 N-(2,5-difluoro-4-(3-(1-methyl-1H-pyrazol-4-yl)pyridin-4-yloxy)phenyl)-5-(4-fluorophenyl)-1-methyl-4-oxo-1,4-dihydropyridine-3-carboxamide 
• 1345855-10-8 N-(2,5-difluoro-4-(3-(1-methyl-1H-pyrazol-4-yl)pyridin-4-yloxy)phenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide 
• 1345855-06-2 N-(2,5-difluoro-4-(3-(1-methyl-1H-pyrazol-4-yl)pyridin-4-yloxy)phenyl)-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide 
• 1345855-08-4 N-(4-(3-(1-(cyanomethyl)-1H-pyrazol-4-yl)pyridin-4-yloxy)-2,5-difluorophenyl)-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide 
• 1345855-07-3 N-(4-(3-bromopyridin-4-yloxy)-2,5-difluorophenyl)-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide 
• 1225283-32-8 2,5-difluoro-4-(3-(1-methyl-1H-pyrazol-4-yl)pyridin-4-yloxy)benzenamine 

Relevant articles and documents

PYRIDONE AMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITES

Compounds useful in the treatment of mammalian cancers and especially human cancers according to Formula I are disclosed. Pharmaceutical compositions and methods of treatment employing the compounds disclosed herein are also disclosed.